Unless otherwise noted, all growth rates in this Release refer to same period in prior year. 2. Please see detailed guidance ...

One of the secrets to living a longer, better life is beating in our chests. An estimated 80% of cardiovascular disease (CVD) can be prevented with lifestyle changes and available tools, yet it ...

Acute myeloid leukemia (AML), the most common form of acute leukemia in adults, is a cancer of the blood and bone marrow. Prognosis and survival rate may depend on numerous factors.

Reshema Kemps-Polanco is Executive Vice President and Chief Commercial Officer, Novartis US, responsible for the expansion of medicines across oncology, immunology, neurology, and cardiovascular, ...

About Novartis in Cardiovascular Disease At Novartis, our mission is to ensure no heart is lost too soon. We envision a world where preventable CV deaths are no longer part of our lives. We’re proud ...

. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result ...

Select units of Cosentyx to be made available at 55% discount off list price on direct-to-patient (DTP) platform beginning November 1, 2025 DTP offering to expand to other appropriate products; ...

Basel, January 13, 2025 – Novartis is pleased with the decision by the US Court of Appeals for the Federal Circuit (CAFC) that affirms the validity of the Entresto ...

Novartis is betting on both human inquisitiveness and computer expertise to harness the wealth of its digital research and development platform, data42. Although artificial intelligence has been ...

Key data from PSMAddition has been selected for a Presidential session; data to showcase the efficacy and safety of PluvictoTM plus standard of care (SoC) versus SoC alone in PSMA+ mHSPC NATALEE ...

If approved, Scemblix will be indicated for adults with chronic myeloid leukemia (CML), both newly diagnosed and previously treated, expanding access to four times as many patients in Europe Scemblix ...

Behind every transformational leader is a remarkable story. For Reshema Kemps-Polanco, Chief Commercial Officer of Novartis US, it's a journey that weaves together military discipline, a sharp ...